Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply
2020 ◽
Vol 59
(9)
◽
pp. e48-e49
Yoshikazu Nakaoka
◽
Katsuhisa Yamashita
◽
Shinji Yamakido
2020 ◽
Vol 59
(9)
◽
pp. e46-e47
◽
2018 ◽
Vol 79
(3)
◽
pp. AB180
Benjamin Ehst
◽
George Han
◽
Scott Guenthner
◽
Kimberly Eads
◽
Abby Jacobson
Toshinari Odawara
◽
Kazuko Hasegawa
◽
Ritsuko Kajiwara
◽
Hisao Takeuchi
◽
Masaaki Tagawa
◽
...
Varsha Gandhi
◽
Prithviraj Bose
2018 ◽
Vol 12
(2)
◽
pp. 277-291.e3
◽
Jie Bai
◽
Li-lin Gong
◽
Qi-fu Li
◽
Zhi-hong Wang
Donald S. Levy
◽
Henriette Farkas
◽
Marc A. Riedl
◽
Florence Ida Hsu
◽
Joel P. Brooks
◽
...
2018 ◽
Vol 38
(8)
◽
pp. 864-875
◽
Stephen Jolles
◽
Mikhail A. Rojavin
◽
John-Philip Lawo
◽
Robert Nelson
◽
Richard L. Wasserman
◽
...
2020 ◽
Vol 22
(9)
◽
pp. 1516-1526
◽
Chantal Mathieu
◽
Gottfried Rudofsky
◽
Moshe Phillip
◽
Eiichi Araki
◽
Marcus Lind
◽
...
P. Riebling
◽
E. O'Mara
◽
X. Luo
◽
P. Trifillis
◽
T. Ong
Close
Export Citation Format
Close
Share Document
Close